InvestorsHub Logo
Post# of 252317
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 99983

Wednesday, 07/28/2010 10:53:32 AM

Wednesday, July 28, 2010 10:53:32 AM

Post# of 252317
Guess AF listened to Norbert Bischofberger too :)
The virologic failure rate difference was higher in ECHO trial (11.0% vs 4.4%) than in THRIVE (7.1% vs 5.3%), and there's no explanation for this either.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.